The cellular inhibitor of apoptosis protein-2 is a possible target of novel treatment for endometriosis
Lab / animal
OA: bronze
CC0
⤵ 4 in-corpus citations
AI-generated summary
Endometriotic stromal cells exhibit elevated cIAP-2 expression regulated by TNFα/NF-κB, and inhibiting IAPs reduces ESC viability and IL-8, suggesting cIAP-2 as a therapeutic target.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: How is the tumor necrosis factor (TNF) α-induced inhibitor of apoptosis (IAP) protein expression in endometriotic stromal cells (ESCs) involved in cell viability and signaling pathways?
METHOD OF STUDY: Endometriotic stromal cells were isolated from ovarian chocolate cysts in 20 patients who underwent laparoscopic surgery. IAP protein expression and IκB phosphorylation were evaluated by Western blot analysis. Interleukin (IL)-8 protein expression and cell proliferation were assessed by ELISA.
RESULTS: Cellular IAP (cIAP)-2 protein expression in endometriotic tissue was higher than that of endometrium. TNFα markedly enhanced cIAP-2 protein expression in ESCs. Pretreatment with a nuclear factor (NF)-κB inhibitor attenuated TNFα-induced cIAP-2 expression. An antagonist of IAPs abrogated TNFα-induced cIAP-2 protein expression and showed a decrease in TNFα-induced IL-8 protein expression and BrdU incorporation in ESCs.
CONCLUSIONS: TNFα and its downstream NFκB pathway have proven to be critical regulators of highly expressed cIAP-2 in ESCs. cIAP-2 may be a novel therapeutic target for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (45)
- Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues via crossref
- Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues via openalex
- Apigenin inhibits tumor necrosis factor α-induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells via crossref
- Apigenin inhibits tumor necrosis factor α-induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells via openalex
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via crossref
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
- Matrix metalloproteinases and endometriosis via openalex
- Matrix metalloproteinases and endometriosis via crossref
- Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis via crossref
- Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis via openalex
- Pyrrolidine dithiocarbamate inhibits nuclear factor-κB pathway activation, and regulates adhesion, migration, invasion and apoptosis of endometriotic stromal cells via crossref
- Role of cytokines in endometriosis via openalex
- Role of cytokines in endometriosis via crossref
- TAK1 activation for cytokine synthesis and proliferation of endometriotic cells via crossref
- TAK1 activation for cytokine synthesis and proliferation of endometriotic cells via openalex
- The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis via openalex
- The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis via crossref
- Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression via crossref
- Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression via openalex
- Tumor Necrosis Factor- Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein Expression via openalex
- Tumor Necrosis Factor- Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein Expression via crossref
- W2140433977 via openalex
- W2091269867 via openalex
- W2085018432 via openalex
- W2069990321 via openalex
- W2069800916 via openalex
- W2064299413 via openalex
- W2042642675 via openalex
- doi:10.1038/nrd3627 via crossref
- W2002154440 via openalex
- doi:10.1016/s0962-8924(99)01609-8 via crossref
- doi:10.1016/0092-8674(95)90149-3 via crossref
- doi:10.1038/nrm830 via crossref
- doi:10.1158/0008-5472.can-04-1918 via crossref
- doi:10.1172/jci26251 via crossref
- W1989277510 via openalex
- W1984710883 via openalex
- W1976457595 via openalex
- doi:10.1016/j.cell.2007.10.030 via crossref
- doi:10.1126/scisignal.2001878 via crossref
- doi:10.1021/cb600276q via crossref
- doi:10.1016/j.cell.2007.10.037 via crossref
- W1492587973 via openalex
- doi:10.1038/ng.2007.8 via crossref
- W2102675401 via openalex
Cited by (4)
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Inhibition of IAP (inhibitor of apoptosis) proteins represses inflammatory status via nuclear factor-kappa B pathway in murine endometriosis lesions 2017
- Development and pharmacological evaluation of in vitro nanocarriers composed of lamellar silicates containing copaiba oil-resin for treatment of endometriosis 2016
- The oil-resin of the tropical rainforest tree Copaifera langsdorffii reduces cell viability, changes cell morphology and induces cell death in human endometriotic stromal cultures 2015
Source provenance
- crossref
- last seen: 2026-08-27T06:26:14.780178+00:00
- europepmc
- last seen: 2026-10-10T06:11:15.153948+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:13:06.373426+00:00
License: CC0
· commercial use OK